Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments.

Melamed, Osnat C; deRuiter, Wayne K; Buckley, Leslie; Selby, Peter

Melamed, Osnat C; deRuiter, Wayne K; Buckley, Leslie; Selby, Peter.

Melamed OC; Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, Ontario M6J1H4, Canada; Department of Family and Community Medicine, University of Toronto, 500 University Avenue, Toronto, Ontario M5G1V7, Canada.
deRuiter WK; Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, Ontario M6J1H4, Canada.
Buckley L; Addictions Division, Centre for Addiction and Mental Health, 1001 Queen Street West, Toronto, Ontario M6J1H4, Canada; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario M5T1R8, Canada.
Selby P; Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, Ontario M6J1H4, Canada; Department of Family and Community Medicine, University of Toronto, 500 University Avenue, Toronto, Ontario M5G1V7, Canada; Department of Psychiatry, University of Toronto, 2

Psychiatr Clin North Am ; 45(1): 95-107, 2022 03.

Article in English | MEDLINE | ID: covidwho-1665394

ABSTRACT

ABSTRACT

Coronavirus disease 2019 (COVID-19)-related stressors and restrictions, in the absence of social and institutional support, have led many individuals to either increase their substance consumption or relapse. Consequently, treatment programs for substance use disorders (SUDs) made a transition from in-person to remote care delivery. This review discusses the following evidence regarding changes prompted by the COVID pandemic to the clinical care of individuals with SUDs (1) reduction in availability of care, (2) increase in demand for care, (3) transition to telemedicine use, (4) telemedicine for treatment of opioid use disorders, and (5) considerations for use of telemedicine in treating SUDs.

Subject(s)

COVID-19; Opioid-Related Disorders; Substance-Related Disorders; Telemedicine; Humans; Opioid-Related Disorders/drug therapy; Pandemics; SARS-CoV-2; Substance-Related Disorders/epidemiology; Substance-Related Disorders/therapy

Keywords

COVID-19; Digital technology; Opioid use disorder; Pandemic; Substance use disorder treatment; Telemedicine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Telemedicine / Substance-Related Disorders / COVID-19 / Opioid-Related Disorders Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Psychiatr Clin North Am Year: 2022 Document Type: Article Affiliation country: J.psc.2021.11.006

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google